Drug Discovery and Development Strategies for COVID-19
Abstract
Coronavirus Disease 2019 (COVID-19) has emerged as a global
threat. Scientists and clinicians are endeavoring to find effective
drugs and vaccines for this disease. This special issue of the
Europasian Journal of Medical Sciences (EJMS) aims to cover
the problems, solutions, and challenges of COVID-19 around
the world. In this Editorial, EJMS Editors Aarajana Shrestha and
Tara Man Kadayat highlight the processes of drug discovery and
development and a brief overview of the current drug development
strategies against COVID-19.
Copyright (c) 2020 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author/s as the copyright holder will retain the ownership of the copyrights without restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
